Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,043 DKK | -0.58% | +1.68% | -4.41% |
05-21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
05-15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.41% | 19.27B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.48% | 21.97B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B | |
-29.20% | 7.77B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Affirms Upgraded FY22 Guidance Amid Higher Sales of Cancer Drug Darzalex